Cargando…
WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
The incidence of brain metastases (BM) is estimated between 20% and 40% of patients with solid cancer. The most common cause of this failure is lung cancer, and in locally advanced non-small cell lung cancer (NSCLC) BM represent a common site of relapse in 30–55% cases. The basic criteria of therape...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182552/ https://www.ncbi.nlm.nih.gov/pubmed/34164217 http://dx.doi.org/10.21037/jtd-2019-rbmlc-06 |